Global Pain Therapeutics Market and Modality Trends Report 2026: Currently 391 Innovator Drugs for Pain Indications with Nociceptive Pain Market Expected to See the Highest Growth Rate to ...
Cassava Sciences, Inc. (SAVA)
Last cassava sciences, inc. earnings: 8/12 08:30 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
molecule type, and capitalizing on the fast-growing nociceptive pain sector. Formulating strategic partnerships and exploring robust pipelines can also provide competitive advantages. Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Market & ModalityTrends: Global PainTherapeutics Market" report has been added to ResearchAndMarkets.com's offering. The current pain market is dominated by NSAIDs and opioids. There are currently 391 innovator drugs marketed for pain indications globally. The pain market is highly genericized, with generics accounting for 98% of all marketed pain drugs globally. The most significant R&D trend in pain is the emergence of voltage-gated sodium channel (NaV) inhibitors, in particular NaV1.8 and NaV1.7, as a validated therapeutic modality. Compared with the marketed landscape, there is more diversity in the pain pipeline in terms of molecule types, routes of administration, and targets. The neuropathic pain market is the largest of the pain types, val
Show less
Read more
Impact Snapshot
Event Time:
SAVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SAVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SAVA alerts
High impacting Cassava Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
SAVA
News
- Filana Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
- Cassava Sciences (SAVA) was upgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=SAVA&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "sell" tMarketBeat
- Cassava Sciences says US DOJ has closed investigation into company [Yahoo! Finance]Yahoo! Finance
- Cassava Announces Closure of U.S. Department of Justice InvestigationGlobeNewswire
- Cassava Sciences (NASDAQ:SAVA) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=SAVA&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street ZMarketBeat
SAVA
Sec Filings
- 3/12/26 - Form 8-K
- 3/10/26 - Form 8-K
- 2/19/26 - Form 8-K
- SAVA's page on the SEC website